Cibus, Inc. (CBUS)
USD 3.35
(-10.67%)
USD 3.35
(-10.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -46.21 Million | -19.36 Million | -18.81 Million | -43.67 Million | -31.95 Million | -20.25 Million |
| Net Income | -337.63 Million | -16.89 Million | -29.19 Million | -44.83 Million | -39.61 Million | -27.89 Million |
| Depreciation & Amortization | 4.69 Million | 1.53 Million | 2.33 Million | 1.86 Million | 1.6 Million | 1.08 Million |
| Deferred income taxes | -1.7 Million | - | - | -313 Thousand | - | - |
| Stock-based compensation | 16.09 Million | 3.99 Million | 2.09 Million | 4.97 Million | 9.17 Million | 4.38 Million |
| Change in working capital | 961 Thousand | -2.88 Million | 7.48 Million | -5.67 Million | -3.12 Million | 2.16 Million |
| Other non-cash items | 271.38 Million | -5.12 Million | -1.52 Million | 313 Thousand | 15.84 Million | 11 Thousand |
| Investing Cash Flow | 55.06 Million | -1.52 Million | 11.2 Million | -13.48 Million | -2.96 Million | -1.79 Million |
| Investments in PPE | -4.32 Million | -1.52 Million | -497 Thousand | -1.78 Million | -2.96 Million | -1.84 Million |
| Acquisitions | 59.38 Million | - | - | - | - | - |
| Investment purchases | - | - | - | -11.69 Million | - | - |
| Sales/Maturities of investments | - | - | 11.69 Million | - | - | - |
| Other Investing Activities | 59.38 Million | - | 11.69 Million | -11.69 Million | - | 50 Thousand |
| Financing Cash Flow | 20.32 Million | 9.98 Million | 3.74 Million | 15.4 Million | -330 Thousand | 60.67 Million |
| Debt repayment | -1.57 Million | -376 Thousand | -364 Thousand | -360 Thousand | -275 Thousand | -1.24 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -230 Thousand |
| Common Stock Issuance | 20.3 Million | 11.53 Million | 4.38 Million | 15 Million | 344 Thousand | 57.7 Million |
| Other Financing Activities | 1.58 Million | -1.17 Million | -274 Thousand | 767 Thousand | -55 Thousand | 3.19 Million |
| Accounts receivables | 1.7 Million | - | 4.88 Million | -3.76 Million | -1.12 Million | - |
| Accounts payables | 2000.00 | -229 Thousand | -360 Thousand | -148 Thousand | 259 Thousand | -193 Thousand |
| Inventory | -915 Thousand | - | 1.38 Million | 1.21 Million | -2.59 Million | - |
| Other working capital | 170 Thousand | -2.65 Million | 1.57 Million | -2.97 Million | 336 Thousand | 2.36 Million |
| Cash at beginning of period | 3.52 Million | 14.42 Million | 18.28 Million | 60.03 Million | 95.28 Million | 56.66 Million |
| Cash at end of period | 32.69 Million | 3.52 Million | 14.42 Million | 18.28 Million | 60.03 Million | 95.28 Million |
| Capital Expenditure | -4.32 Million | -1.52 Million | -497 Thousand | -1.78 Million | -2.96 Million | -1.84 Million |
| Effect of forex changes on cash | 3000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 29.17 Million | -10.89 Million | -3.86 Million | -41.74 Million | -35.25 Million | 38.62 Million |
| Free Cash Flow | -50.53 Million | -20.88 Million | -19.3 Million | -45.45 Million | -34.92 Million | -22.09 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.88 Million | -26.97 Million | -337.63 Million | -277.2 Million | -34.52 Million | -20.5 Million |
| Depreciation & Amortization | 1.73 Million | 1.79 Million | 4.69 Million | 1.81 Million | 1.68 Million | 705 Thousand |
| Deferred income taxes | - | - | -1.7 Million | 249.54 Million | 1.22 Million | - |
| Stock-based compensation | 2.81 Million | 2.52 Million | 16.09 Million | 4.42 Million | 5.82 Million | 5.01 Million |
| Change in working capital | -308 Thousand | 473 Thousand | 961 Thousand | -3.75 Million | 2.95 Million | 877 Thousand |
| Other non-cash items | 10.95 Million | 8.3 Million | 271.38 Million | 8.16 Million | 7.76 Million | 2.16 Million |
| Investing Cash Flow | -169 Thousand | -228 Thousand | 55.06 Million | -449 Thousand | -3.31 Million | 58.82 Million |
| Investments in PPE | -169 Thousand | -228 Thousand | -4.32 Million | -449 Thousand | -3.31 Million | -560 Thousand |
| Acquisitions | - | - | 59.38 Million | - | - | 59.38 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 59.38 Million | - | - | 59.38 Million |
| Financing Cash Flow | 22.73 Million | 5.51 Million | 20.32 Million | 18.27 Million | -619 Thousand | 1.75 Million |
| Debt repayment | -226 Thousand | -434 Thousand | -1.57 Million | -570 Thousand | -619 Thousand | -286 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 23.04 Million | 6.53 Million | 20.3 Million | 20.3 Million | - | - |
| Other Financing Activities | -87 Thousand | -581 Thousand | 1.58 Million | -1.45 Million | - | 2.04 Million |
| Accounts receivables | -408 Thousand | -120 Thousand | 1.7 Million | 30 Thousand | 297 Thousand | 1.37 Million |
| Accounts payables | -670 Thousand | 646 Thousand | 2000.00 | 63 Thousand | 2.2 Million | -2.25 Million |
| Inventory | - | - | -915 Thousand | -3.38 Million | 1.12 Million | - |
| Other working capital | 770 Thousand | -531 Thousand | 170 Thousand | -468 Thousand | -675 Thousand | 3.13 Million |
| Cash at beginning of period | 24.5 Million | 32.69 Million | 3.52 Million | 31.88 Million | 50.89 Million | 2.05 Million |
| Cash at end of period | 30.02 Million | 24.5 Million | 32.69 Million | 32.69 Million | 31.88 Million | 50.89 Million |
| Capital Expenditure | -169 Thousand | -228 Thousand | -4.32 Million | -449 Thousand | -3.31 Million | -560 Thousand |
| Effect of forex changes on cash | -2000.00 | -3000.00 | 3000.00 | 5000.00 | -7000.00 | 5000.00 |
| Net cash flow / Change in cash | 5.51 Million | -8.19 Million | 29.17 Million | 816 Thousand | -19.01 Million | 48.84 Million |
| Free Cash Flow | -17.21 Million | -13.7 Million | -50.53 Million | -17.46 Million | -18.38 Million | -12.3 Million |
MADHUSE
BVSFF
AJMERA
VBBR3
BKGI
HAVI